Background illustration for clinical trials search

Paid Clinical Trials San Antonio

Discover 994 paid clinical trials in San Antonio, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: San Antonio TX, Sugar Land TX, Grapevine TX, Tulsa OK,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: San Antonio TX, Austin TX, Bellaire TX, Frisco TX,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man

for
Insulin Resistance
Location: San Antonio TX
Sponsor: Elahi, Dariush, PhD

Sex: All

Age: 18 - 65

Code: NCT02518932

Phase 1, Recruiting

Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

for
Rheumatoid Arthritis
Location: San Antonio TX, Lenexa KS, Salt Lake City UT
Sponsor: Dr. Reddy's Laboratories Limited

Sex: Male

Age: 18 - 50

Code: NCT06126042

Phase 1, Recruiting

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for
Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer,
Location: San Antonio TX, Denver CO, Nashville TN, Chicago IL,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06756035

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

for
Obesity, Overweight
Location: San Antonio TX
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 65

Code: NCT07738614

Phase 1, Recruiting

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

for
Moderate-to-severe Chronic Plaque Psoriasis
Location: San Antonio TX, Webster TX, Glendale AZ,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07362017

Phase 3, Recruiting

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: San Antonio TX, Missouri City TX, Dallas TX,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07783542

Phase 2, Recruiting

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: San Antonio TX, Sugar Land TX, Dallas TX, Plainfield IN,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18+

Code: NCT07643766

Phase 2, Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: San Antonio TX, Bellaire TX, Webster TX, Dallas TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase 3, Recruiting

Microassay and Allergy Skin Prick Test Correlation Study

for
Allergy Pollen
Location: San Antonio TX
Sponsor: United Allergy Services

Sex: All

Age: 18+

Code: NCT03514303

Recruiting
New

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

for
Non-Small Cell Lung Cancer
Location: San Antonio TX, Beaumont TX, Palm Bay FL, Winchester VA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07680790

Phase 3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: San Antonio TX, Austin TX, Fort Worth TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: San Antonio TX, Austin TX, Houston TX, Spring TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: San Antonio TX, Houston TX, Galveston TX, Daphne AL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: San Antonio TX, Laredo TX, Galveston TX, Dallas TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: San Antonio TX, New Braunfels TX, Fredericksburg TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase 2, Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: San Antonio TX, Austin TX, Waco TX, McAllen TX,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: San Antonio TX, New Braunfels TX, Fredericksburg TX,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase 3, Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for
Diabetic Nephropathies,
Location: San Antonio TX, Houston TX, Denver CO, Atlanta GA,
Sponsor: Walden Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06466135

Phase 2, Recruiting

With a robust healthcare network and several renowned medical research institutions, San Antonio is a key hub for clinical research. Leading organizations such as UT Health San Antonio, Brooke Army Medical Center, and the Texas Biomedical Research Institute are at the forefront of groundbreaking studies.

These institutions are recognized for their expertise in areas like cancer, infectious diseases, trauma care, and military health, positioning San Antonio as an important city in advancing medical research and improving patient outcomes.

Why choose San Antonio for clinical trials?

For those keen to participate in clinical trials, San Antonio offers distinct advantages. The city’s diverse population provides a wide range of participants, making research findings more reliable and applicable across various demographics.

By joining a clinical trial in San Antonio, participants not only gain access to cutting-edge treatments but also contribute to critical advancements in medical research. The city’s well-established research infrastructure and supportive medical community ensure high-quality care and valuable contributions.

Common conditions studied in San Antonio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in San Antonio